| Literature DB >> 31461852 |
Gerald T Mangine1, Brian M Kliszczewicz2, Joseph B Boone2, Cassie M Williamson-Reisdorph2, Emily E Bechke2.
Abstract
To evaluate the feasibility of on-site collection of subjective anxiety, autonomic nervous system activity, and salivary catecholamines surrounding high-intensity functional training (HIFT) competition, ten experienced HIFT competitors completed baseline assessments of anxiety and heart rate variability (HRV). Then, in two consecutive weeks (Workout 1 and 2) within the competition, HRV was recorded and examined in 5-min segments prior to exercise (PRE) and across a 30-min period after competitors completed their choice of the prescribed or scaled each workout. Subjective anxiety ratings and saliva samples were collected at PRE and immediately-(IP), 30-min (30P), and 60-min post-exercise (60P). Saliva samples were analyzed for concentrations of epinephrine and norepinephrine. Generalized linear mixed models with repeated measures revealed significant (p < 0.05) differences between workouts for all measures. Compared to Workout 1, anxiety (~50%), epinephrine (173-340%), norepinephrine (29-234%) were greater in Workout 2 and various HRV-derived indices were more depressed. Additionally, some HRV-derived indices appeared to be modulated (p < 0.05) by competitive level and sex at PRE and throughout the 30-min recovery period. These data suggest that autonomic activity may differ between the competitive and laboratory settings, and that the response may be further modulated by the workout's design, the athlete's sex, and competitive level.Entities:
Keywords: CrossFit; catecholamines; heart rate variability; high-intensity functional training; recreational athletes
Year: 2019 PMID: 31461852 PMCID: PMC6784172 DOI: 10.3390/sports7090199
Source DB: PubMed Journal: Sports (Basel) ISSN: 2075-4663
Workout descriptions and performance scores for (male / female) competitors of the 2016 Open (mean ± standard deviation).
| Rx | Scaled | |
|---|---|---|
| Workout 1 | 7-min AMRAP | 7-min AMRAP |
| Type | ||
| Exercises | 10 power snatches (75 / 55 lbs.) | 10 power snatches (45 / 35 lbs.) |
| Max Score * | 420 repetitions (195 repetitions) | 225 repetitions |
|
| ||
| Men | 275 ± 9 repetitions (80 ± 9 repetitions) | - |
| Women | 229 ± 34 repetitions (34 ± 34 repetitions) | 100 ± 48 repetitions |
| Total | 262 ± 27 repetitions (67 ± 27 repetitions) | 100 ± 48 repetitions |
| Workout 2 | 13-min AMRAP | 13-min AMRAP |
| Type | ||
| Exercises | 55 deadlifts (225 / 155 lbs.) | 55 deadlifts (135 / 95 lbs.) |
| Max Score * | 1320 repetitions (660 repetitions) | 660 repetitions |
|
| ||
| Men | 847 ± 9 repetitions (187 ± 9 repetitions) | - |
| Women | 825 repetitions (165 repetitions) | 195 ± 68 repetitions |
| Total | 844 ± 12 repetitions (184 ± 12 repetitions) | 195 ± 68 repetitions |
Note: AMRAP = As many repetitions as possible; Rx = As prescribed. * Rx competitors are always ranked above scaled competitors, regardless of score. Thus, max score for Rx competitors is indicated by the number of repetitions completed in addition to the maximum possible scaled score. The actual number of repetitions completed is indicated within parentheses.
Figure 1Changes in heart rate comparisons between (A) men and women; and (B) Rx and Scaled competitors.
Figure 2Changes in saliva concentrations of (A) Epinephrine and (B) Norepinephrine.
Figure 3lnRMSS comparisons between Workouts 1 and Workout 2.
Figure 4Sex and week comparisons for (A) lnHF; (B) lnLF; and (C) LF:HF ratio.
Figure 5Competitive level and week comparisons for (A) lnHF; (B) lnLF; and (C) LF:HF ratio.